API

Active Pharmaceutical Ingredients (API), popularly speaking, are the raw materials of medicines, only pharmaceutical raw materials are processed into pharmaceutical preparations , can they become medicines available for clinical use, so drugs we usually eat are the finished drugs through processing. Active Pharmaceutical Ingredients based on its sources can be divided into two major categories ,including chemical synthetic drugs and natural chemical drugs. Chemical synthetic drugs can be divided into organic synthetic drugs and inorganic synthetic drugs. Inorganic synthetic drugs are inorganic compounds ( very few is element), such as aluminum hydroxide, magnesium trisilicate which are used for the treatment of gastric and duodenal ulcers ; organic synthetic drugs are mainly composed of drugs made by basic organic chemical raw materials, through a series of organic chemical reactions (such as aspirin, chloramphenicol, caffeine, etc.). Natural chemical drugs ,based on its sources,can be divided into two categories including biochemical drugs and plant chemical drugs. Antibiotics are generally made by the microbial fermentation, which belongs to the biochemistry category. A variety of semi-synthetic antibiotics occurs in recent years,which are biosynthesis and chemical synthesis combining products.Among active Pharmaceutical Ingredients, the organic synthetic drugs varieties, yields and values have the largest proportion,which are the main pillars of the chemical and pharmaceutical industries. The quality of active Pharmaceutical Ingredients decides whether the formulation is good or bad , so its quality standards are very strict ,countries in the world have developed national pharmacopoeia standards and strict quality control methods for its widely used active Pharmaceutical ingredients.

Thyrotropin-releasing hormone: Clinical Studies and Safety

Thyrotropin-releasing hormone shows promise in treating severe epilepsies, with significant seizure reduction and favorable safety profile. Further trials are needed for optimization.

Jan 16,2025  API

Benefits and Side Effects of Xylitol

Xylitol is a nutritive sweetener that can be used as a substitute for sucrose or glucose. Xylitol is found in very small amounts in many plants, especially strawberries, raspberries, and broccoli.

Jan 16,2025  API

Sodium stibogluconate: uses and side effects

Sodium stibogluconate, a synthetic pentavalent antimonial agent, is a medication used to treat cutaneous, visceral, and mucosal leishmaniasis, a parasitic infection transmitted by sand-fly bites.

Jan 16,2025  API

Is Xanthan gum safe for daily use as a food additive?

Xanthan gum is an FDA-approved food additive (stabilizer and emulsifier) without any restrictions. It is soluble in cold water and quickly produces a viscous, stable solution when in water, even at lo

Jan 16,2025  API

Maprotiline hydrochloride: a tetracyclic antidepressant

Maprotiline hydrochloride, USP is a tetracyclic anti depressant, available as 25 mg, 50 mg and 75 mg tab lets for oral administration.

Jan 16,2025  API

Q:What is the difference between D-(-)-Tartaric Acid and D(+)-tartaric acid?

A:D-(-)-Tartaric Acid and D(+)-tartaric acid are both D-enantiomers of tartaric acid. They are similar but come from different sources, so they are easily confused.

Jan 15,2025  API

Can retinoic acid be used to treat cancer?

Yes. Retinoic acid (RA), also known as all-trans retinoic acid, ATRA, retinoic acid and vitamin A acid, is an endogenous signaling molecule that regulates many developmental processes.

Jan 15,2025  API

Orotic Acid:Synthesis, Biochemical Aspects and Physiological Role

Orotic acid is an normal organic acid with the molecular formula C?H?N?O?, which is widely used in the food, health care and feed industries.

Jan 15,2025  API

Rivastigmine tartrate: uses and Synthesis method

Rivastigmine Tartrate (RT) is an acetylcholinesterase inhibitor that reversibly inhibits both the acetylcholinesterase and butyrylcholinesterase enzymes, which is superior in terms of specificity of a

Jan 15,2025  API

Tolylene-2,4-diisocyanate: Dermal Exposure and carcinogenicity

Limited data on Tolylene-2,4-diisocyanate complicates dermal exposure assessment. Respiratory effects and carcinogenicity risks are evident, but uncertainties persist.

Jan 15,2025  API
Prev12345678910...Next>  Go to Page